Scientists in the US are developing a drug which may help prevent serious allergic reactions in those with peanut allergies. The drug, TNX-901, which is at least three years away from going on the market, is designed to block the action of immunoglobulin-E, or IgE, a molecule that plays a major part in asthma and allergies, reports BBC News Online.